← Back to headlines
ANI Pharmaceuticals Exceeds Q4 Expectations
ANI Pharmaceuticals reported Non-GAAP EPS of $2.33, beating estimates by $0.35, and revenue of $247.1M, surpassing expectations by $16.07M.
27 Feb, 12:05 — 27 Feb, 12:05
ℹOnly 1 source covers this story
